| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.900 | None | 0.946 | 13 | 0 | 1991 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.500 | None | 0.991 | 12 | 0 | 1988 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.700 | None | 0.972 | 9 | 0 | 1997 | 2020 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.400 | None | 0.960 | 6 | 0 | 1999 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 1.000 | 5 | 0 | 2005 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 0.962 | 5 | 0 | 1994 | 2019 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
disease | 0.400 | None | 0.980 | 5 | 0 | 1991 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.936 | 5 | 0 | 1994 | 2020 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
disease | 0.100 | None | 0.929 | 4 | 0 | 2006 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.100 | None | 0.967 | 4 | 0 | 2002 | 2019 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
disease | 0.250 | None | 1.000 | 4 | 0 | 2002 | 2017 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.100 | None | 0.909 | 4 | 0 | 1995 | 2014 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 0.977 | 3 | 0 | 1995 | 2019 | ||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
disease | 0.400 | None | 0.933 | 3 | 0 | 2002 | 2018 | ||||||||
|
tenascin C | 0.433 | 0.846 | 1.3E-07 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 1992 | 2019 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2005 | 2018 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.958 | 3 | 0 | 1994 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.920 | 3 | 0 | 2001 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 1997 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.979 | 3 | 0 | 2004 | 2019 | ||||||||
|
secreted protein acidic and cysteine rich | 0.445 | 0.846 | 0.89 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2001 | 2019 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
disease | 0.040 | None | 1.000 | 3 | 0 | 2001 | 2011 | ||||||||
|
leucine rich glioma inactivated 1 | 0.568 | 0.731 | 1.00 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1998 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 0.909 | 3 | 0 | 1991 | 2019 | ||||||||
|
slit guidance ligand 2 | 0.511 | 0.769 | 1.00 |
|
disease | 0.060 | None | 1.000 | 3 | 0 | 2003 | 2016 |